The host-associated microbiota is increasingly recognized to facilitate host fitness, but the understanding of the underlying ecological processes that govern the host-bacterial colonization over development and, particularly, under disease remains scarce. Here, we tracked the gut microbiota of shrimp over developmental stages and in response to disease. The stage-specific gut microbiotas contributed parallel changes to the predicted functions, while shrimp disease decoupled this intimate association. After ruling out the age-discriminatory taxa, we identified key features indicative of shrimp health status. Structural equation modelling revealed that variations in rearing water led to significant changes in bacterioplankton communities, which subsequently affected the shrimp gut microbiota. However, shrimp gut microbiotas are not directly mirrored by the changes in rearing bacterioplankton communities. A neutral model analysis showed that the stochastic processes that govern gut microbiota tended to become more important as healthy shrimp aged, with 37.5% stochasticity in larvae linearly increasing to 60.4% in adults. However, this defined trend was skewed when disease occurred. This departure was attributed to the uncontrolled growth of two candidate pathogens (over-represented taxa). The co-occurrence patterns provided novel clues on how the gut commensals interact with candidate pathogens in sustaining shrimp health. Collectively, these findings offer updated insight into the ecological processes that govern the host-bacterial colonization in shrimp and provide a pathological understanding of polymicrobial infections.
Gut microbiota has been demonstrated to be involved in intestinal nutrition, defense, and immunity, as well as participating in disease progression. This study was to investigate gut microbiota changes in chickens challenged with
netB
-positive
Clostridium perfringens
strain (CP1) and/or the predisposing
Eimeria
species (
Eimeria
) and fed diets with fishmeal supplementation. In addition, the effects of lauric acid, a medium-chain fatty acid (MCFA), on necrotic enteritis (NE) reduction and modulation of microbiota were evaluated. The results demonstrated that microbial communities in the jejunum were distinct from those in the cecum, and the microbial community change was more significant in jejunum. Challenge of CP1 in conjunction with
Eimeria
significantly reduced species diversity in jejunal microbiota, but cecal microbiota remained stable. In the jejunum, CP1 challenge increased the abundance of the genera of
Clostridium sensu stricto 1
,
Escherichia Shigella
, and
Weissella
, but significantly decreased the population of
Lactobacillus
.
Eimeria
infection on its own was unable to promote NE, demonstrating decrements of
Clostridium sensu stricto 1
and
Lactobacillus
. Co-infection with CP1 and
Eimeria
reproduced the majority of NE lesions with significant increment of C
lostridium sensu stricto 1
and reduction in
Lactobacillus
. The advance of changes on these two taxa increased the severity of NE lesions. Further analyses of metagenomeSeq, STAMP, and LEfSe consistently showed significant overgrowth of
Clostridium sensu stricto 1
was associated with NE. The supplementation of lauric acid did not reduce NE incidence and severity but decreased the relative abundance of
Escherichia Shigella
. In conclusion, significant overgrowth of
C
.
perfringens as well as other Clostridium
species in
Clostridium sensu stricto 1
with the decrement of
Lactobacillus
in the jejunum is the featured microbiota correlated with NE. Controlling proliferation of
Clostridium sensu stricto 1
and manipulation of
Lactobacillus
in the jejunum should be the strategy to prevent NE.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.